Sharon Barbari is on the board of Agile Therapeutics, Inc., The Association of Bioscience Financial Officers and VYNE Therapeutics, Inc. In the past Ms. Barbari was Chief Financial Officer of Gilead Sciences, Inc., Chief Financial Officer, Secretary & Executive VP at Cytokinetics, Inc., CFO, Senior VP-Finance & Administration at InterMune, Inc. and Vice President-Strategic Planning at Foote, Cone & Belding Healthcare.

Ms. Barbari received an undergraduate degree from San Jose State University.